A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines

点击次数:

发表刊物:Targ Oncol

是否译文:

发表时间:2015-04-01

论文类型:期刊论文

通讯作者:李力